The CAREGENE study: Polymorphisms of the β1-adrenoceptor gene and aerobic power in coronary artery disease

European Heart Journal

Volumn 27, Issue 7, 2006, Pages 808-816

  Defoor, Johan ^a   Martens, Kevin ^b   Zielińska, Dominika ^c   Matthijs, Gert ^b   Van Nerum, Hilde ^a   Schepers, Dirk ^a   Fagard, Robert ^a   Vanhees, Luc ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adrenergic receptor; Cardiac rehabilitation; Exercise; Genetics; Oxygen uptake; Polymorphism

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; GLYCINE; SERINE;

ADULT; AEROBIC EXERCISE; ARTICLE; CONTROLLED STUDY; COVARIANCE; DNA POLYMORPHISM; EXERCISE TEST; FEMALE; GENOTYPE; HAPLOTYPE; HEART REHABILITATION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TRAINING;

CORONARY ARTERIOSCLEROSIS; EXERCISE; EXERCISE TEST; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1;

EID: 33645025622     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi737     Document Type: Article

References (46)

1. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 2002;106:666-671.
2. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001;345:892-902.
3. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612-628.
4. Gielen S, Schuler G, Hambrecht R. Exercise training in coronary artery disease and coronary vasomotion. Circulation 2001;103:E1-E6.
5. Giannuzzi P, Saner H, Bjornstad H, Fioretti P, Mendes M, Cohen-Solal A, Dugmore L, Hambrecht R, Hellemans I, McGee H, Perk J, Vanhees L, Veress G. Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur Heart J 2003;24:1273-1278.
6. Wilmore JH, Green JS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C. Relationship of changes in maximal and submaximal aerobic fitness to changes in cardiovascular disease and non-insulin-dependent diabetes mellitus risk factors with endurance training: the HERITAGE Family Study. Metabolism 2001;50:1255-1263.
7. Vanhees L, Fagard R, Thijs L, Amery A. Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary-bypass surgery. Am J Cardiol 1995;76:1014-1019.
8. Vanhees L, Stevens A, Schepers D, Defoor J, Rademakers F, Fagard R. Determinants of the effects of physical training and of the complications requiring resuscitation during exercise in patients with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2004;11:304-312.
9. 2max in the sedentary state: the HERITAGE family study. Med Sci Sports Exerc 1998;30:252-258.
10. Montoye HJ, Gayle R. Familial relationships in maximal oxygen uptake. Hum Biol 1978;50:241-249.
11. Bouchard C, Lesage R, Lortie G, Simoneau JA, Hamel P, Boulay MR, Perusse L, Theriault G, Leblanc C. Aerobic performance in brothers, dizygotic and monozygotic twins. Med Sci Sports Exerc 1986;18:639-646.
12. Fagard R, Van Den BC, Bielen E, Amery A. Maximum oxygen uptake and cardiac size and function in twins. Am J Cardiol 1987;60:1362-1367.
13. Fagard R, Bielen E, Amery A. Heritability of aerobic power and anaerobic energy generation during exercise. J Appl Physiol 1991;70:357-362.
14. Maes HH, Beunen GP, Vlietinck RF, Neale MC, Thomis M, Vanden Eynde B, Lysens R, Simons J, Derom C, Derom R. Inheritance of physical fitness in 10-yr-old twins and their parents. Med Sci Sports Exerc 1996;28:1479-1491.
15. Prud'homme D, Bouchard C, Leblanc C, Landry F, Fontaine E. Sensitivity of maximal aerobic power to training is genotype-dependent. Med Sci Sports Exerc 1984;16:489-493.
16. (2max) response to exercise training: results from the HERITAGE Family Study. J Appl Physiol 1999;87:1003-1008.
17. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA. Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994;63:101-132.
18. Brodde OE, Bruck H, Leineweber K, Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 2001;96:528-538.
19. Bulbring E, Tomita T. Catecholamine action on smooth muscle. Pharmacol Rev 1987;39:49-96.
20. Van Baak MA. Beta-adrenoceptor blockade and exercise: an update. Sports Med 1988;5:209-225.
21. Maqbool A, Hall AS, Ball SG, Balmforth AJ. Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet 1999;353:897.
22. Hoehe MR, Otterud B, Hsieh WT, Martinez MM, Stauffer D, Holik J, Berrettini WH, Byerley WF, Gershon ES, Lalouel JM. Genetic mapping of adrenergic receptor genes in humans. J Mol Med 1995;73:299-306.
23. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB. Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat 1999;14:271.
24. Rathz DA, Brown KM, Kramer LA, Liggett SB. Amino acid 49 polymorphisms of the human betal-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002;39:155-160.
25. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999;274:12670-12674.
26. Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn GW, Liggett SB. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 2002;144:840-846.
27. 2max criteria: discontinuous vs continuous protocols. Med Sci Sports Exerc 1997;29:273-278.
28. Wasserman K, Hansen J, Sue D, Whipp B. Physiology of exercise. In: Wasserman K, Hansen J, Sue D, Whipp B,ed. Principles of Exercise Testing and Interpretation. Philadelphia: Lea & Febiger; 1999. p10-61.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
30. de Arruda M, Lyamichev VI, Eis PS, Iszczyszyn W, Kwiatkowski RW, Law SM, Olson MC, Rasmussen EB. Invader technology for DNA and RNA analysis: principles and applications. Expert Rev Mol Diagn 2002;2:487-496.
31. Hall JG, Eis PS, Law SM, Reynaldo LP, Prudent JR, Marshall DJ, Allawi HT, Mast AL, Dahlberg JE, Kwiatkowski RW, de Arruda M, Neri BP, Lyamichev VI. Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natt Acad Sci USA 2000;97:8272-8277.
32. Hessner MJ, Budish MA, Friedman KD. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin Chem 2000;46:1051-1056.
33. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-1169.
34. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
35. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L, Groop L. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 2001;104:187-190.
36. Molenaar P, Rabnott G, Yang I, Fong KM, Savarimuthu SM, Li L, West MJ, Russell FD. Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 2002;40:1275-1282.
37. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:7920-7924.
38. Buscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S, Hoyer PF, Michel MC, Insel PA, Brodde OE. In vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001;11:199-205.
39. Sandilands AJ, O'Shaughnessy KM, Brown MJ. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors vs Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 2003;138:386-392.
40. Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, Stein CM. Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-197.
41. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 2000;99:233-238.
42. Karlsson J, Lind L, Hallberg P, Michaelsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Melhus H. Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol 2004;27:347-350.
43. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002;70:935-942.
44. Vanhees L, Fagard R, Amery A. Influence of beta adrenergic blockade on effects of physical training in patients with ischaemic heart disease. Br Heart J 1982;48:33-38.
45. Podlowski S, Wenzel K, Luther HP, Muller J, Bramlage P, Baumann G, Felix SB, Speer A, Hetzer R, Kopke K, Hoehe MR, Wallukat G. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000;78:87-93.
46. Vanhees L, Fagard R, Amery A. Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men. Eur J Appl Physiol Occup Physiol 1988;58:87-91.